P

PerkinElmer Inc
LSE:0KHE

Watchlist Manager
PerkinElmer Inc
LSE:0KHE
Watchlist
Price: 111.2382 USD 1.38% Market Closed
Market Cap: 1.2T USD
Have any thoughts about
PerkinElmer Inc?
Write Note

Gross Margin
PerkinElmer Inc

55.4%
Current
58%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.4%
=
Gross Profit
1.5B
/
Revenue
2.7B

Gross Margin Across Competitors

Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.9B USD
Gross Margin
41%
Country US
Market Cap 165.5B USD
Gross Margin
60%
Country KR
Market Cap 67.5T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.4B USD
Gross Margin
55%
Country US
Market Cap 36.2B USD
Gross Margin
35%
Country US
Market Cap 26.8B USD
Gross Margin
59%
Country US
Market Cap 23.9B USD
Gross Margin
35%
Country CN
Market Cap 163.8B CNY
Gross Margin
40%
Country US
Market Cap 22B USD
Gross Margin
60%
No Stocks Found

PerkinElmer Inc
Glance View

Market Cap
1.2T USD
Industry
Life Sciences Tools & Services
Economic Moat
None

PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.

0KHE Intrinsic Value
1.6311 USD
Overvaluation 99%
Intrinsic Value
Price
P

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
55.4%
=
Gross Profit
1.5B
/
Revenue
2.7B
What is the Gross Margin of PerkinElmer Inc?

Based on PerkinElmer Inc's most recent financial statements, the company has Gross Margin of 55.4%.